在开窗/分支支架移植时代,在没有定制设备的中心,开放与血管内复杂主动脉瘤修复的长期结果

IF 3.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE
Jesse Manunga, Hamza Hanif, Ellen Cravero, Sara Behmanesh, Elliot Stephenson, Ross M Clark, Nedaa Skeik, Mohammad Khasawneh, Kevin M Harris, Muhammad Ali Rana
{"title":"在开窗/分支支架移植时代,在没有定制设备的中心,开放与血管内复杂主动脉瘤修复的长期结果","authors":"Jesse Manunga, Hamza Hanif, Ellen Cravero, Sara Behmanesh, Elliot Stephenson, Ross M Clark, Nedaa Skeik, Mohammad Khasawneh, Kevin M Harris, Muhammad Ali Rana","doi":"10.1016/j.jvs.2025.08.045","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate and compare long-term outcomes of complex aortic aneurysms (cAAs) treated with open surgical repair (OR) or fenestrated/branched endovascular aneurysm repair (F/B-EVAR) between 2010 and 2023 at two institutions.</p><p><strong>Methods: </strong>This retrospective analysis compares outcomes of cAAs treated by OR vs. F/B-EVAR at two centers with no access to custom made fenestrated/branched devices. cAAs were defined as those requiring a suprarenal or higher clamp (OR) or unsuitable for commercially available infrarenal endografts. Primary endpoints were technical success and major adverse events (MAEs); secondary endpoints included target vessel patency, re-intervention rate, and long-term survival. MAEs encompassed in-hospital death, stroke, MI, paraplegia, renal insufficiency, dialysis, return to the operating room, target vessel loss, and conversion to open repair.</p><p><strong>Results: </strong>507 patients (OR: 157; F/B-EVAR: 350) underwent cAA repair. Majority were male (76%) with a median age of 74 (68, 80) years. F/B-EVAR patients were older and had higher comorbidities (p>0.001). For OR, clamp site was suprarenal/supramesenteric in 143 (91.1%) and intrathoracic in 14 (8.9%) patients with thoracoabdominal aneurysms. Complications were higher in patients requiring supraceliac clamp. In the F/B-EVAR group, 99.4% of 1,239 target vessels were successfully incorporated. The overall technical success rate was 97% (OR: 100%, F/B-EVAR: 96%). Thirty-day mortality was similar between groups (F/B-EVAR: 3.4%; OR: 1.9%, p=0.4), as were MAEs (F/B-EVAR: 20%; OR: 15%, p=0.12). However, operating room time, estimated blood loss, and ICU/hospital length of stay were higher in the OR group (p<0.001). Paraplegia occurred only in the F/B-EVAR group (1.7%), while pneumonia and wound complications were more common in the OR group (p<0.001). At a median follow-up of 60 months, actuarial 5-year survival was significantly higher in the OR group (89% vs. 85%, p=0.041). Long-term reintervention rates were similar (OR: 7.4%, F/B-EVAR: 5.1%, p=0.3).</p><p><strong>Conclusion: </strong>Both approaches are safe and effective for cAA repair. F/B-EVAR offers perioperative advantages - faster recovery and shorter ICU/hospital stays - while OR provides excellent long-term outcomes in selected patients. Comprehensive aortic centers should maintain expertise in both techniques to optimize individualized treatment.</p>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-Term Outcomes of Open versus Endovascular Complex Aortic Aneurysm Repairs at Centers Without Access to Custom Made Devices in the Fenestrated/Branched Stent-Graft Era.\",\"authors\":\"Jesse Manunga, Hamza Hanif, Ellen Cravero, Sara Behmanesh, Elliot Stephenson, Ross M Clark, Nedaa Skeik, Mohammad Khasawneh, Kevin M Harris, Muhammad Ali Rana\",\"doi\":\"10.1016/j.jvs.2025.08.045\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate and compare long-term outcomes of complex aortic aneurysms (cAAs) treated with open surgical repair (OR) or fenestrated/branched endovascular aneurysm repair (F/B-EVAR) between 2010 and 2023 at two institutions.</p><p><strong>Methods: </strong>This retrospective analysis compares outcomes of cAAs treated by OR vs. F/B-EVAR at two centers with no access to custom made fenestrated/branched devices. cAAs were defined as those requiring a suprarenal or higher clamp (OR) or unsuitable for commercially available infrarenal endografts. Primary endpoints were technical success and major adverse events (MAEs); secondary endpoints included target vessel patency, re-intervention rate, and long-term survival. MAEs encompassed in-hospital death, stroke, MI, paraplegia, renal insufficiency, dialysis, return to the operating room, target vessel loss, and conversion to open repair.</p><p><strong>Results: </strong>507 patients (OR: 157; F/B-EVAR: 350) underwent cAA repair. Majority were male (76%) with a median age of 74 (68, 80) years. F/B-EVAR patients were older and had higher comorbidities (p>0.001). For OR, clamp site was suprarenal/supramesenteric in 143 (91.1%) and intrathoracic in 14 (8.9%) patients with thoracoabdominal aneurysms. Complications were higher in patients requiring supraceliac clamp. In the F/B-EVAR group, 99.4% of 1,239 target vessels were successfully incorporated. The overall technical success rate was 97% (OR: 100%, F/B-EVAR: 96%). Thirty-day mortality was similar between groups (F/B-EVAR: 3.4%; OR: 1.9%, p=0.4), as were MAEs (F/B-EVAR: 20%; OR: 15%, p=0.12). However, operating room time, estimated blood loss, and ICU/hospital length of stay were higher in the OR group (p<0.001). Paraplegia occurred only in the F/B-EVAR group (1.7%), while pneumonia and wound complications were more common in the OR group (p<0.001). At a median follow-up of 60 months, actuarial 5-year survival was significantly higher in the OR group (89% vs. 85%, p=0.041). Long-term reintervention rates were similar (OR: 7.4%, F/B-EVAR: 5.1%, p=0.3).</p><p><strong>Conclusion: </strong>Both approaches are safe and effective for cAA repair. F/B-EVAR offers perioperative advantages - faster recovery and shorter ICU/hospital stays - while OR provides excellent long-term outcomes in selected patients. Comprehensive aortic centers should maintain expertise in both techniques to optimize individualized treatment.</p>\",\"PeriodicalId\":17475,\"journal\":{\"name\":\"Journal of Vascular Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Vascular Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jvs.2025.08.045\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jvs.2025.08.045","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

目的:评价和比较2010年至2023年间两所医院采用开放手术修复(OR)或开窗/分支血管内动脉瘤修复(F/B-EVAR)治疗复杂主动脉瘤(cAAs)的长期疗效。方法:本回顾性分析比较了两个中心使用OR和F/B-EVAR治疗cAAs的结果,这些中心没有定制的开窗/分支装置。cAAs被定义为需要肾上或更高的夹钳(or)或不适合市售的肾下内移植物。主要终点为技术成功和主要不良事件(MAEs);次要终点包括靶血管通畅、再干预率和长期生存。MAEs包括院内死亡、中风、心肌梗死、截瘫、肾功能不全、透析、返回手术室、靶血管丢失和转开腹修复。结果:507例患者(OR: 157; F/B-EVAR: 350)接受了cAA修复。大多数为男性(76%),中位年龄为74岁(68岁,80岁)。F/B-EVAR患者年龄较大,合并症较高(p < 0.001)。对于胸腹动脉瘤,143例(91.1%)患者钳位在肾上/肠上,14例(8.9%)在胸内。需要腹腔上夹的患者并发症较高。在F/B-EVAR组中,1239个靶血管中99.4%成功合并。总体技术成功率为97% (OR: 100%, F/B-EVAR: 96%)。30天死亡率组间相似(F/B-EVAR: 3.4%; OR: 1.9%, p=0.4), MAEs组间相似(F/B-EVAR: 20%; OR: 15%, p=0.12)。然而,手术室时间、估计失血量和ICU/住院时间均高于OR组(p结论:两种方法对cAA修复均安全有效。F/B-EVAR提供围手术期优势——更快的恢复和更短的ICU/住院时间——而OR在选定的患者中提供了良好的长期结果。综合主动脉中心应保持两种技术的专业知识,以优化个体化治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Long-Term Outcomes of Open versus Endovascular Complex Aortic Aneurysm Repairs at Centers Without Access to Custom Made Devices in the Fenestrated/Branched Stent-Graft Era.

Objective: To evaluate and compare long-term outcomes of complex aortic aneurysms (cAAs) treated with open surgical repair (OR) or fenestrated/branched endovascular aneurysm repair (F/B-EVAR) between 2010 and 2023 at two institutions.

Methods: This retrospective analysis compares outcomes of cAAs treated by OR vs. F/B-EVAR at two centers with no access to custom made fenestrated/branched devices. cAAs were defined as those requiring a suprarenal or higher clamp (OR) or unsuitable for commercially available infrarenal endografts. Primary endpoints were technical success and major adverse events (MAEs); secondary endpoints included target vessel patency, re-intervention rate, and long-term survival. MAEs encompassed in-hospital death, stroke, MI, paraplegia, renal insufficiency, dialysis, return to the operating room, target vessel loss, and conversion to open repair.

Results: 507 patients (OR: 157; F/B-EVAR: 350) underwent cAA repair. Majority were male (76%) with a median age of 74 (68, 80) years. F/B-EVAR patients were older and had higher comorbidities (p>0.001). For OR, clamp site was suprarenal/supramesenteric in 143 (91.1%) and intrathoracic in 14 (8.9%) patients with thoracoabdominal aneurysms. Complications were higher in patients requiring supraceliac clamp. In the F/B-EVAR group, 99.4% of 1,239 target vessels were successfully incorporated. The overall technical success rate was 97% (OR: 100%, F/B-EVAR: 96%). Thirty-day mortality was similar between groups (F/B-EVAR: 3.4%; OR: 1.9%, p=0.4), as were MAEs (F/B-EVAR: 20%; OR: 15%, p=0.12). However, operating room time, estimated blood loss, and ICU/hospital length of stay were higher in the OR group (p<0.001). Paraplegia occurred only in the F/B-EVAR group (1.7%), while pneumonia and wound complications were more common in the OR group (p<0.001). At a median follow-up of 60 months, actuarial 5-year survival was significantly higher in the OR group (89% vs. 85%, p=0.041). Long-term reintervention rates were similar (OR: 7.4%, F/B-EVAR: 5.1%, p=0.3).

Conclusion: Both approaches are safe and effective for cAA repair. F/B-EVAR offers perioperative advantages - faster recovery and shorter ICU/hospital stays - while OR provides excellent long-term outcomes in selected patients. Comprehensive aortic centers should maintain expertise in both techniques to optimize individualized treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.70
自引率
18.60%
发文量
1469
审稿时长
54 days
期刊介绍: Journal of Vascular Surgery ® aims to be the premier international journal of medical, endovascular and surgical care of vascular diseases. It is dedicated to the science and art of vascular surgery and aims to improve the management of patients with vascular diseases by publishing relevant papers that report important medical advances, test new hypotheses, and address current controversies. To acheive this goal, the Journal will publish original clinical and laboratory studies, and reports and papers that comment on the social, economic, ethical, legal, and political factors, which relate to these aims. As the official publication of The Society for Vascular Surgery, the Journal will publish, after peer review, selected papers presented at the annual meeting of this organization and affiliated vascular societies, as well as original articles from members and non-members.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信